RSI under 30 viser, at momentummet i aktien er stærkt negativt. Aktien er faldet meget på kort tid uden særlige reaktioner op undervejs. Investorerne er stadig gået ned i pris for at få solgt deres aktier. Det indikerer, at flere er på vej ud, at pessimismen tager til, og at kursen vil fortsætte ned.
Tidligere blev RSI under 30 af mange anset for at være en god købsmulighed. Sådanne aktier var såkaldt oversolgte efter, at de var faldet for meget på kort tid. Teorien forudså, at de ville få en snarlig reaktion op. Ifølge Investtechs forskning har sådanne aktier imidlertid tydeligt underpræsteret i forhold til markedet.
Følgende gælder for lav RSI:
Aktier med lav RSI har negativt momentum, og vores forskningsresultater indikerer, at man bør holde sig væk fra disse. Mentalt kan det være fristende at købe sådanne aktier, fordi de er faldet meget og let opfattes som billige. Lav RSI indikerer imidlertid, at pessimismen vil fortsætte med at stige, og at nedgangen vil fortsætte.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.